Panima Pharmaceuticals Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Panima Pharmaceuticals General Information

Description

Manufacturer of bio-pharmaceutical products. The company's bio-pharmaceutical products specialize in the discovery of antibodies for the treatment of neurological disorders, enabling the patients to get cured.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Wagistrasse 13
  • 8952 Schlieren
  • Switzerland
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • Wagistrasse 13
  • 8952 Schlieren
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Panima Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Panima Pharmaceuticals‘s full profile, request access.

Request a free trial

Panima Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Panima Pharmaceuticals‘s full profile, request access.

Request a free trial

Panima Pharmaceuticals FAQs

  • Where is Panima Pharmaceuticals headquartered?

    Panima Pharmaceuticals is headquartered in Schlieren, Switzerland.

  • What industry is Panima Pharmaceuticals in?

    Panima Pharmaceuticals’s primary industry is Biotechnology.

  • Is Panima Pharmaceuticals a private or public company?

    Panima Pharmaceuticals is a Private company.

  • What is the current valuation of Panima Pharmaceuticals?

    The current valuation of Panima Pharmaceuticals is .

  • What is Panima Pharmaceuticals’s current revenue?

    The current revenue for Panima Pharmaceuticals is .

  • Who are Panima Pharmaceuticals’s investors?

    Neurimmune has invested in Panima Pharmaceuticals.

  • When was Panima Pharmaceuticals acquired?

    Panima Pharmaceuticals was acquired on 17-Dec-2010.

  • Who acquired Panima Pharmaceuticals?

    Panima Pharmaceuticals was acquired by Biogen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »